Verano Holdings (VRNO) Change in Taxes (2021 - 2026)
Verano Holdings (VRNO) posted quarterly Change in Taxes of -$812000.0 for Q1 2026, up 95.92% year-over-year from -$414454.4 in Q1 2025, and up 88.98% quarter-over-quarter from -$7.4 million in Q4 2025.
Verano Holdings (VRNO) Change in Taxes (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has reported Change in Taxes for 6 consecutive years, with -$812000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Taxes rose 95.92% year-over-year to -$812000.0; the TTM figure through Mar 2026 stood at -$32.7 million (up 85.45% YoY), while the FY2025 annual figure was -$51.8 million, up 73.46% from the prior year.
- Change in Taxes advanced to -$812000.0 in Q1 2026 per VRNO's latest filing, from -$7.4 million in the prior quarter.
- Across five years, Change in Taxes topped out at $60.2 million in Q3 2022 and bottomed at -$231.7 million in Q4 2024.
- Historically, Change in Taxes has averaged -$9.2 million across 5 years, with a median of -$5.0 million in 2023.
- On a YoY basis, Change in Taxes climbed as much as 291.25% in 2024 and fell as far as 9052.75% in 2024.
- Verano Holdings' Change in Taxes stood at $30.4 million in 2022, then tumbled by 108.31% to -$2.5 million in 2023, then plunged by 9052.75% to -$231.7 million in 2024, then soared by 96.82% to -$7.4 million in 2025, then soared by 88.98% to -$812000.0 in 2026.
- Business Quant data shows VRNO's Change in Taxes at -$812000.0 in Q1 2026, -$7.4 million in Q4 2025, and -$17.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -106.03 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 40.90 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -59.60 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Verano Holdings | 449.04 Mn | 363.85 Mn | 99.70 Mn | -11.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11.31 Mn |
| Jun 30, 2026 | -11.31 Mn |
| Mar 31, 2026 | -812,000.00 |
| Mar 31, 2026 | -812,000.00 |
| Dec 31, 2025 | -7.37 Mn |
| Dec 31, 2025 | -7.37 Mn |
| Sep 30, 2025 | -16.96 Mn |
| Sep 30, 2025 | -16.96 Mn |
| Jun 30, 2025 | -7.55 Mn |
| Jun 30, 2025 | -7.55 Mn |
| Mar 31, 2025 | -19.90 Mn |
| Mar 31, 2025 | -19.90 Mn |
| Dec 31, 2024 | -231.66 Mn |
| Dec 31, 2024 | -231.66 Mn |
| Sep 30, 2024 | 33.75 Mn |
| Sep 30, 2024 | 33.75 Mn |
| Jun 30, 2024 | -6.83 Mn |
| Jun 30, 2024 | -6.83 Mn |
| Mar 31, 2024 | 9.60 Mn |
| Mar 31, 2024 | 9.60 Mn |